Effectiveness and Safety of SAR156597 in Treating Diffuse Systemic Sclerosis

Clinical trial NCT02921971 · COMPLETED

Trial details

NCT number: NCT02921971
Sponsor: Sanofi
Status: COMPLETED
Phase: Phase 2
Study type: INTERVENTIONAL

Systemic Sclerosis

Start date: 2016-12-21
Primary completion: 2019-01-14
Enrollment: 97

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.